Health Care insider buying
46 health care companies had open-market insider purchases in the last 30 days, ranked below by dollar value. The buyers include officers, directors and 10% owners, and a 10% owner can be a fund. All health care companies ยท How to read insider buying
Purchase value (30d)
46| # | Ticker / Company | Purchase value (30d) |
|---|---|---|
| 1 |  $LYCA Lycia Therapeutics, Inc. | $38.30M |
| 2 |  $ASPE Aspen Neuroscience, Inc. | $38.00M |
| 3 |  $RAPP Rapport Therapeutics, Inc. | $22.02M |
| 4 |  $BBTX Bambusa Therapeutics, Inc. | $12.00M |
| 5 |  $SRRK Scholar Rock Holding Corp | $12.00M |
| 6 |  $IAM Iambic Therapeutics, Inc. | $11.50M |
| 7 |  $AVR Anteris Technologies Global Corp. | $8.67M |
| 8 |  $CTY CITY THERAPEUTICS, INC. | $6.12M |
| 9 |  $PRTA PROTHENA CORP PUBLIC LTD CO | $4.82M |
| 10 |  $TRXB TRex Bio, Inc. | $3.80M |
| 11 |  $TENX TENAX THERAPEUTICS, INC. | $1.46M |
| 12 |  $PLUR Pluri Inc. | $1.25M |
| 13 |  $ONMD OneMedNet Corp | $1000K |
| 14 |  $KRRO Korro Bio, Inc. | $885K |
| 15 |  $OM Outset Medical, Inc. | $870K |
| 16 |  $INBX Inhibrx Biosciences, Inc. | $849K |
| 17 |  $XBIT XBiotech Inc. | $711K |
| 18 |  $IRIX IRIDEX CORP | $598K |
| 19 |  $ACOG Alpha Cognition Inc. | $574K |
| 20 |  $CNXU Conexeu Sciences Inc. | $500K |
| 21 |  $GRCE Grace Therapeutics, Inc. | $456K |
| 22 |  $BOLD Boundless Bio, Inc. | $427K |
| 23 |  $ATEC Alphatec Holdings, Inc. | $409K |
| 24 |  $AGMB AgomAb Therapeutics NV | $400K |
| 25 |  $RTSN Retension Pharmaceuticals, Inc. | $370K |
| 26 |  $XGN EXAGEN INC. | $104K |
| 27 |  $INM InMed Pharmaceuticals Inc. | $86K |
| 28 |  $STSS Sharps Technology Inc. | $78K |
| 29 |  $UTMD UTAH MEDICAL PRODUCTS INC | $67K |
| 30 |  $ANIX Anixa Biosciences Inc | $61K |
| 31 |  $QTEX QTREX Quantum Ltd. | $61K |
| 32 |  $PETV PetVivo Holdings, Inc. | $56K |
| 33 |  $NXTC NextCure, Inc. | $54K |
| 34 |  $ACTU ACTUATE THERAPEUTICS, INC. | $50K |
| 35 |  $PMN ProMIS Neurosciences Inc. | $44K |
| 36 |  $VRXA Veraxa Biotech AG - Post de-SPAC | $43K |
| 37 |  $STIM Neuronetics, Inc. | $41K |
| 38 |  $DYN Dyne Therapeutics, Inc. | $40K |
| 39 |  $PALI PALISADE BIO, INC. | $29K |
| 40 |  $ELTP ELITE PHARMACEUTICALS INC | $26K |
| 41 |  $OTLC Oncotelic Therapeutics, Inc. | $24K |
| 42 |  $LITS Lite Strategy, Inc. | $13K |
| 43 |  $NRXS Neuraxis, INC | $12K |
| 44 |  $XFOR X4 Pharmaceuticals, Inc | $12K |
| 45 |  $NNOX Nano-X Imaging Ltd. | $11K |
| 46 |  $AIM AIM ImmunoTech Inc. | $10K |
Why sector matters for insider buying
Insider buying is easier to read next to its own sector. Company officers know their industry's cycle better than the market's. When insiders at several health care companies buy in the same month, the buying points at the industry, which the same number of purchases spread across unrelated industries would not.
Only purchases (SEC Form 4 transaction code P) count. Grants, option exercises and shares withheld for tax are left out: they are pay, not a decision to buy, and counting them would rank sectors by payroll.